MCURE Co., Ltd. will release painless drug injector Aquagent TDI next month

News provided by
M CURE
October 26, 2012 10:33 Korea Standard Time
  • MCURE Co., Ltd. will release painless drug injector Aquagent TDI next month

    MCURE Co., Ltd. will release painless drug injector Aquagent TDI next month

WONJU--(Korea Newswire)--MCURE Co., Ltd. (CEO, Man-Gyu Lee, www.mcure.co.kr) a manufacturer specialized in medical equipment, will release the painless drug injector Aquagent TDI with the much upgraded function of the hydro lifting treatment device Aquagent in November.

Since the double clutch vacuum in Aquagent TDI, which was developed for the first time in the world by MCURE Co., Ltd., injects the drug through absorbing skin with the air pressure method, it is almost painless and it can easily inject the drug with high viscosity. And it solves the inconvenience of the patients since it enables to do treatment without applying anesthetic gel at the same time as the shortened treatment time due to the fast injection time.

In addition, it is possible to control the value of the time and pressure in overall through the smart GUI LCD of 7 inches color depending on the ease of users.

Moreover, it maintains the accuracy of treatment since it is possible to inject a moisturizing element with the exact pressure in the precise location without bleeding, which is the biggest advantage of the existing Aquagent.

Thus, it is suitable for aging skin, wound treatment, whitening, treatment of stretch marks and treatment of hair loss while being possible to inject a moisturizing element in various layers of the skin such as epidermis, dermis, etc. And the company is currently progressing export contracts with a variety of countries including Germany, Russia and China.

Aquagent TDI can increase even further the effect of skin care if it is used together with the cosmetic device SRT that was developed before. The PST (power stitch technic) technology of the SRT product enhances wrinkle improvement, collapsed scar, moisturizing, skin elasticity, etc. through injecting sequentially hyaluronic acid and carbon dioxide gas, which are the moisturizing elements, in the desired depth in the skin.

“Aguagent TDI, that we will soon release, has significantly improved the problem of the hydro lifting treatment that has been recently attracting attention as the baby face treatment through developing the double clutch vacuum,” Hyung Sam Kim, Marketing Director, said. “We expect it to solve both the ease of operators and the fear of patients.” ( Inquiries : +82-70-8260-5976, mcure@mcure.co.kr)

Website: http://www.mcure.co.kr

Contact

MCURE
+82-70-8260-5976

This is a news release distributed by Korea Newswire on behalf of this company.